Press release
CevareinforcesitspositioninChinaandswinethroughnewjoint-venturewithEBVAC
Beijing,GreatHallofthePeople,21st.February2016:InthepresenceoftheChinesePrimeMinister,Li Keqiang and French PrimeMinister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVACtodaysignedajoint-ventureagreementtocreateanewbusiness,CevaEBVAC,focusedontheswinesector.Chinaisbyfarthelargestglobalproducerofporkwithhalfoftheworld’spigsbeingraisedinthecountry,underliningtheimportanceofthenewpartnershipforbothcompanies.
DrMarcPrikazsky,CevaChairmanandCEO;MaHongChao,CAHECCEO;DuYuanZhao,YebioCEO;
BernardCazeneuve,FrenchPrimeMinister;LiKeqiang,ChinesePrimeMinisterhttps://drive.google.com/file/d/0By_u-iKfinNnQVlMZ0RiY0N0Q28/view?usp=sharing
EBVACwas founded in 2005byChinaAnimalHealth andEpidemiologyCenter (CAHEC), through itssubsidiarycompanyQingdaoYebio,apartoftheNationalInstituteoftheMinistryofAgriculture.ThecompanyisbasedinHangzhouCity,neartoShanghaiandfocusesonvaccineresearch,productionandservice.In2016itachievedsalesof140m.RMB(19m.Euro)andhasaveragedgrowthof20%paforthe past 5 yrs. Swine vaccines are themajor driver of this growth, representingmore than 55%ofsales.Thecompany is recognizedasaNationalHigh-TechEnterpriseandhasabroadnetworkofscientificpartnerships with local research institutes and universities and an international R&D joint-venturewiththeUniversityofCambridge,UK,CAMBIVAC.
CevaisaFrench-basedmultinationalbiopharmaceuticalgroup,theworld’s6thlargest,withabalancedofferingofvaccinesandpharmaceuticalproductsforswineproducers.
Ceva will hold the majority of shares in the new partnership and through the addition of its ownproducts to theEBVACportfolioofvaccines,aimstocreatean innovative,market leadingcompany.CevahasbeenpresentinChinafor15yearsandsince2011hasenteredintoanumberofpartnerships(joint-ventureCevaHuadu,scientificcooperationagreementwithSouthChinaAgriculturalUniversity(SCAU),trainingprogrammeforproducersandveterinarianswiththeUniversityofBeijing)designedtoshareknowledgeandensurethatthecompany'sinternationalswineexpertisecanbeappliedtolocalconditionsanddiseasesinChina.
ThisnewcompanyCevaEBVACwillbenefitfromtheextensivescientificnetworksalreadyestablishedbyitstwopartners,whohavebothagreedtoinvestsignificantlyinanewresearchanddevelopmentprogramme.
Inaddition,EBVAChas recentlymadesignificant investment tobuildaworldclass, industrial facilitythatwillpermitthisnewdynamicinR&Dtobeconvertedintovaccinesofthehighestquality.
Finally,combiningthe2salesforcesandtrainingthemtorolloutCeva'sinnovativeswinemanagementprogrammes-LungprogrammeandRespinomicswillallowthecompanytoreachmanymoreswineproducers and encourage them to adopt the “new-style professional farming methods”recommendedbyGovernmentinitslatest5yearplan.
Dr.MarcPrikazsky,ChairmanandManagingDirectorofCevacommented:“IamdelightedthatEBVACand their shareholders have accepted our offer to create this exciting, new partnership. China is acountry that no global animal health company can ignore. Given that half of the world’s pigs areraised here and demand for pork products is set to rise even further, if you are not present in thismarket,yousimplycannotbeconsideredaglobalswinecompany."
Morephotosavailablehere(©CevaSantéAnimale):https://drive.google.com/drive/folders/0By_u-iKfinNnbmphRngya3BmdzQ?usp=sharing
-ENDS-
AboutCevaSantéAnimale
Ceva Santé Animale was founded in 1999 and is a global veterinary health company, focused on research,development, production and pharmaceutical products and vaccines for companion animals, livestock, swineandpoultry.Itispresentin110countriesandpostsdouble-digitgrowtheachyear,reachingsalesof€912Min2016.Thecompanyemploysover4,500peoplearoundtheworld.Since2007,itsmanagementandemployeeshavebeenthemajorityshareholdersinCeva,whichischairedbyDrMarcPrikazsky.Website:www.ceva.com
CevaSantéAnimale
PRESSCONTACTMartinMitchellCommunicationDirector+330557554080martin.mitchell@ceva.com
